Latest Litigation News

Ovanti Limited has announced a complete global exit from the Buy Now Pay Later sector, ceasing all BNPL activities and shifting its focus to its established iSentric business in Southeast Asia, alongside significant cost reductions and imminent legal action against its former US BNPL CEO.

Dexus (ASX: DXS) reported steady FY26 results with AFFO of 45.0 cents per security and distributions of 37.0 cents, while initiating a strategic review of infrastructure funds following an adverse APAC court judgment.

Medibank Private Limited reported a 27.5% jump in net profit after tax to $638.7 million for FY26, driven by steady health insurance growth and a 31.3% surge in its Medibank Health segment. The company declared a fully franked final dividend of 10.9 cents per share and updated its Net Zero emissions strategy.

Yowie Group's revenue declined in the first half of 2026 as it navigated supply chain shifts and cautious retail demand, but the company secured a significant Australian licensing deal and ended costly legacy litigation.

Solvar Limited posted a 6.2% decline in statutory net profit for FY26 to $29.5 million, while normalised earnings rose 7.5%. The lender declared a 19.5 cents fully franked dividend and expanded its Australian loan book by 10.5%, driven by growth in commercial lending.

BHP Group Limited posted robust FY2026 results with a 15% revenue increase, record copper production contributing over half of underlying EBITDA, and a total fully franked dividend of 172 US cents per share. The company advances growth projects, including the Jansen potash mine, while managing legacy Samarco liabilities and pursuing climate targets.

Celsius Resources faces a lifted court protection on its 40% MMCI stake amid disputes over capital increases and a contested copper offtake deal with Kiri Industries, setting the stage for arbitration.

ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.

Sarama Resources has offloaded its Cosmo and Mt Venn gold projects to Riedel Resources, securing a substantial equity stake while progressing a US$242 million arbitration claim against Burkina Faso.

Sequoia Financial Group has scrapped its fully franked interim dividend for the half-year ended December 2025, citing ongoing Federal Court proceedings and related legal claims. The Board prioritises capital preservation and risk reduction as the company navigates complex litigation tied to its InterPrac subsidiary.

ASX Limited reported a 13.3% rise in operating revenue to $1.25 billion for FY26, with underlying net profit up 5.2%, despite a 3.5% dip in statutory profit due to significant one-off costs including a $20.5 million ASIC penalty. The company declared a fully franked final dividend of 104.7 cents per share and appointed Anthony Attia as CEO.

Dateline Resources faces a US court injunction halting operations at its Colosseum Project, while ASX suspends and then reinstates trading over disclosure timing concerns.